Human Subject Research
The mission of Geisinger Health Systems Institutional Review Board (IRB) is to advocate for the rights and welfare of human research participants and to promote high quality research by fostering an institutional culture embodying the highest ethical standards of human research.
The Human Research Protection Program (HRPP) administers the institutional program to protect individuals who participate in research, provides administrative support to the IRB and assists staff to promote the protection of the participants of research. HRPP staff provides guidance to investigators in the proposal process, design and conduct of human subjects research; develops educational resources and programs for research staff; and reviews research for quality purposes and compliance with applicable federal law and local policies.
Review and approval is required for all research involving human participants conducted by the Geisinger Health System. Approval must be obtained prior to including human participants in research investigation. For further information and instructions, please contact Geisinger’s HRPP office.
The Institutional Review Board (IRB) has the responsibility for ensuring that the rights of all human participants in research at Geisinger Health System are protected. The IRB is also responsible for making sure that the research is performed in accordance with federal, state, and local regulations and institutional policies. These activities are coordinated through the Human Research Protection Program Office (HRPP). For information on Geisinger’s current clinical trials and how to participate, please contact Geisinger Health System’s Clinical Trials Office.
Human Research Protection Program
Weis Center for Research
100 North Academy Ave.
Danville, PA 17822
Phone: 570.271. 8663